이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

뇌졸중 생존자와 간병인을 위한 MyStroke

2026년 11월 6일 업데이트: Christopher Favilla, University of Pennsylvania

뇌졸중 생존자와 간병인을 위한 개별화된 비디오 기반 뇌졸중 교육 플랫폼

The goal of this multicenter randomized trial is to evaluate the impact of a personalized video-based stroke education platform on patient-centered and health system-centered outcomes. The main questions this study aims to address are:

  1. Does a personalized, video-based educational platform improve stroke knowledge?
  2. Does a personalized, video-based educational platform reduce post-discharge health system utilization?
  3. Do different strategies of nudging improve engagement with educational material after hospital discharge?

In order to determine the effect of this personalized stroke education strategy, researchers will compare subjects who receive standard stroke education with those who receive the personalized stroke education platform in addition to standard standard education. Patient knowledge will be assessed 90-days after discharge. Study participants will include both stroke patients and caregivers, who will:

  1. Receive standard education during the stroke hospitalization
  2. Complete a survey on the day of hospital discharge to assess their baseline knowledge.
  3. Half of the subjects will be randomly assigned to also receive access to the personalized stroke education platform on the day of discharge.
  4. All subjects will complete two follow-up study visits (7 and 90 days after discharge) in order to complete surveys.

연구 개요

상태

아직 모집하지 않음

개입 / 치료

상세 설명

Stroke education represents a unique opportunity to empower stroke survivors (and caregivers) to promote self-management, augment adherence, and reduce post-stroke healthcare utilization. Despite being a key quality metric for stroke centers, most patient and caregiver education is poorly retained and a common source of dissatisfaction. In fact, most survivors are unaware of the cause of their stroke, their modifiable risk factors, and how to properly respond to future stroke symptoms. Although there is no gold standard, most centers rely on a combination of bedside verbal communication and standardized printed materials. Prior work has clarified that effective and durable educational interventions benefit from engaging content, personalization, accessibility, and low cost/burden. Retention is very poor during the stroke hospitalization, but this can be overcome by promoting ongoing engagement after discharge.

To that end, our group developed a web-based educational platform (MyStroke) that leverages the electronic health record to personalize video-based educational content for each stroke survivor. Simple but engaging videos are curated to address each patient's stroke etiology, individualized risk factors, prescribed stroke prevention medications, and post-stroke lifestyle issues. This approach transforms point-of-care stroke education, and integrated nudges reveal opportunities for re-education and re-engagement after hospital discharge to achieve a durable impact. In a recent single-center pilot trial, MyStroke improved patient and caregiver satisfaction and improved key elements of stroke knowledge. The objective of this proposal is to build upon our encouraging preliminary experience and conduct a multicenter randomized trial to evaluate the impact of MyStroke on both patient-centered (stroke knowledge, self-efficacy, satisfaction, quality of life) and health system-centered outcomes (medication adherence and health system utilization).

Electronic nudges will leverage principles of behavioral economics (i.e. enhanced nudges) to promote ongoing engagement. Our preliminary data indicate that even bland nudges promote engagement, but here we propose to use both bland nudges and enhanced nudges, such that platform analytics will compare the influence of different nudge types. Use of technology in this context stands to bridge geographic distances, connect stakeholders, and increase access to information, but it important to recognize the potential to exacerbate inequities for elderly patients and those with limited access to technology. Issues of digital inclusivity will be evaluated to reveal opportunities for platform improvement. The MyStroke platform offers a scalable solution stroke education which imposes no burden on the clinical team due to its reliance on a limited number of input fields which can be harvested from the electronic health record to individualized content for each patient.

연구 유형

중재적

등록 (추정된)

690

단계

  • 해당 없음

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 연락처

연구 연락처 백업

연구 장소

    • Pennsylvania
      • Lancaster, Pennsylvania, 미국, 17602
      • Philadelphia, Pennsylvania, 미국, 19104
      • Philadelphia, Pennsylvania, 미국, 19104
        • The Hospital of the University of Pennsylvania
      • Philadelphia, Pennsylvania, 미국, 19107
      • West Chester, Pennsylvania, 미국, 19380
        • Chester County Hospital

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

18년 이상 (성인, 고령자)

건강한 자원 봉사자를 받아들입니다

아니

연구 대상 성별

모두

설명

Inclusion Criteria:

  • At least 18 years old
  • Admitted to hospital with clinical diagnosis of acute ischemic stroke (imaging confirmation not required)
  • Stroke symptom onset within 30 days of enrollment
  • Being discharged to either home or an acute rehabilitation facility
  • Access to internet enabled device (smartphone, tablet, computer)
  • Fluent in either English or Spanish (does not need to be native or primary language)
  • Willingness and ability to sign informed consent

Exclusion Criteria:

  • Severe aphasia (score of ≥2 on NIHSS item 9)
  • Ischemic stroke that is attributed to a surgical procedure
  • Resides in a skilled nursing facility prior to admission
  • Being discharged to skilled nursing facility or long-term acute care facility
  • Unwillingness or inability to participate in remote/virtual study visits
  • A terminal or advanced condition that raises the possibility the subject may not survive 90 days
  • Any other illness or condition that the investigator feels would pose a hazard to the subject from participation in the study

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 주 목적: 치료
  • 할당: 무작위
  • 중재 모델: 병렬 할당
  • 마스킹: 삼루타

무기와 개입

참가자 그룹 / 팔
개입 / 치료
간섭 없음: Standard stroke education

Participants in this arm of the study will receive institutional standard stroke education during the course of the hospitalization, standardized across the 5 participating sites. Standard education consists of non-standardized verbal bedside education by the care team, a standardized stroke educational booklet, and standardized verbal instructions by the bedside nurse addressing stroke risk factors and medications.

실험적: MyStroke + standard stroke education

Participants in this arm of the study will receive institutional standard stroke education in addition to access to MyStroke, a personalized video-based education platform. Each participant will receive their personalized page via email or SMS, as per their preference, and they will receive automated nudges to visit educational material after hospital discharge.

MyStroke is a video-based educational platform that curates brief educational videos to inform patients and caregivers about key aspects of their stroke. Upon registering a user, information regarding the patient's stroke etiology, relevant stroke risk factors, and stroke prevention medications are used to populate educational content that is relevant to the individual. Users receive automated nudges to revisit MyStroke after hospital discharge on day 1, 3, 5, 7, and weekly thereafter.

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
The Stroke Patient Education Retention (SPER) survey
기간: 90 days

Total score from the 5-question SPER (scale 0-10; higher score reflects better knowledge)

90 days

2차 결과 측정

결과 측정
측정값 설명
기간
Patient satisfaction with stroke education
기간: 90 days

5-point Likert-scale (Q: I am satisfied with the quality of my stroke education; Answers range from strongly disagree to strongly agree)

90 days
Stroke etiology awareness
기간: 90 days

The proportion of patients who correctly identify their stroke etiology (multiple choice)

90 days
Stroke risk factor awareness
기간: 90 days

The proportion of patients who correctly identify at least one of their vascular risk factors (select all that apply)

90 days
Antithrombotic medication awareness
기간: 90 days

The proportion of patients who correctly identify all prescribed antithrombotic medications (free response)

90 days
Stroke Self-Efficacy Questionnaire (SSEQ)
기간: 90 days

Total score from the 13 item questionnaire (each item scored 0-10; total score 0-130; higher scores represent higher levels of self-efficacy)

90 days
EuroQoL EQ-5D-5L
기간: 90 days

A standardized measure of health-related quality of life across 5 domains. Each domain is scored using a 5-point ordinal scale (1-5), and the Level Sum Score (LSS) is calculated as the sum of the 5 scores (LSS range is 5-25, lower scores represent higher quality of life).

90 days
Medication adherence
기간: 90 days

This will be assessed based on pharmacy record review to quantify the Proportion of Days Covered (PDC). PDC is calculated by dividing the number of days with medications available by the total number of days in question (scored between 0 - 1; higher numbers represent more favorable adherence)

90 days
Emergency Department utilization
기간: 90 days

The number of Emergency Room visits will be summed in the first 90 days following hospital discharge

90 days
Urgent outpatient visits
기간: 90 days

The number of urgent outpatient visits with primary care and neurologist will be summed in the first 90 days following hospital discharge

90 days
Outpatient provider communication
기간: 90 days

The number of communications with primary care or neurology providers via telephone or provider communication apps will be summed in the first 90 days following hospital discharge

90 days

기타 결과 측정

결과 측정
측정값 설명
기간
The Stroke Patient Education Retention (SPER) survey (7 days)
기간: 7 days

Total score from the 5-question SPER (scale 0-10; higher score reflects better knowledge)

7 days
Patient satisfaction with stroke education (7 days)
기간: 7 days

5-point Likert-scale (Q: I am satisfied with the quality of my stroke education; Answers range from strongly disagree to strongly agree)

7 days
Stroke etiology awareness (7 days)
기간: 7 days

The proportion of patients who correctly identify their stroke etiology (multiple choice)

7 days
Stroke risk factor awareness (7 days)
기간: 7 days

The proportion of patients who correctly identify at least one of their vascular risk factors (select all that apply)

7 days
Antithrombotic medication awareness (7 days)
기간: 7 days

The proportion of patients who correctly identify all prescribed antithrombotic medications (free response)

7 days
Stroke Self-Efficacy Questionnaire (SSEQ) (7 days)
기간: 7 days

Total score from the 13 item questionnaire (each item scored 0-10; total score 0-130; higher scores represent higher levels of self-efficacy)

7 days
EuroQoL EQ-5D-5L (7 days)
기간: 7 days

A standardized measure of health-related quality of life across 5 domains. Each domain is scored using a 5-point ordinal scale (1-5), and the Level Sum Score (LSS) is calculated as the sum of the 5 scores (LSS range is 5-25, lower scores represent higher quality of life).

7 days

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

수사관

  • 수석 연구원: Christopher G Favilla, MD, Assistant Professor of Neurology at the University of Pennsylvania

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (추정된)

2026년 11월 1일

기본 완료 (추정된)

2029년 11월 30일

연구 완료 (추정된)

2030년 3월 1일

연구 등록 날짜

최초 제출

2024년 5월 29일

QC 기준을 충족하는 최초 제출

2024년 5월 29일

처음 게시됨 (실제)

2024년 6월 4일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2026년 11월 12일

QC 기준을 충족하는 마지막 업데이트 제출

2026년 11월 6일

마지막으로 확인됨

2026년 1월 1일

추가 정보

이 연구와 관련된 용어

개별 참가자 데이터(IPD) 계획

개별 참가자 데이터(IPD)를 공유할 계획입니까?

예

IPD 계획 설명

Once a manuscript describing such data is accepted for publication, the deidentified dataset contributing to the publication will be shared publicly using the figshare repository (figshare.com). The availability of shared derived data will be described in publications and presentation.

IPD 공유 기간

We anticipate final sharing of data will take place at the completion of the 5-year project, but if an interim analysis results in a publication, the dataset will be shared at that time-point.

IPD 공유 액세스 기준

The data will be publicly available and searchable on figshare (figshare.com), and the availability of shared derived data will be described in publications and presentation.

IPD 공유 지원 정보 유형

  • 연구_프로토콜
  • 수액

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

아니

미국 FDA 규제 기기 제품 연구

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .

구독하다